发明名称 |
NOVEL FOUR-CTL EPITOPE-JOINED PEPTIDE. |
摘要 |
 Provided is a cancer antigen peptide which it is possible to administer as a cancer peptide vaccine to a wide range of cancer patients, without the need for HLA testing, and with no limitation to patients having a specific HLA type. This four CTL epitope-joined peptide is obtained by joining, via linkers, of four CTL epitope peptides selected from a group of CTL epitope peptides derived from a tumor antigen molecule, and which have been reported to have CTL inducibility. |
申请公布号 |
MX2016004754(A) |
申请公布日期 |
2016.07.22 |
申请号 |
MX20160004754 |
申请日期 |
2014.10.20 |
申请人 |
TAIHO PHARMACEUTICAL CO., LTD. |
发明人 |
SATOSHI FUKAYA;TOSHIHIRO OSADA;HIROSHI WADA |
分类号 |
C07K19/00;A61K39/00;A61P35/00;C07K14/00;C07K14/82;C12N5/0783 |
主分类号 |
C07K19/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|